EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Moderate Associations Between the Use of Levonorgestrel-releasing Intrauterine Device and Metabolomics Profile

Elena Toffol iD, Oskari Heikinheimo iD, Pekka Jousilahti, Lara Lehtoranta iD, Anni Joensuu iD, Timo Partonen iD, Iris Erlund iD, Jari Haukka iD

The Journal of Clinical Endocrinology & Metabolism · 2025

DOI: 10.1210/clinem/dgae318 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2025. Verfasst von Elena Toffol und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Public Health, Clinicum, Faculty of Medicine, University of Helsinki, 00014 Helsinki, Finland. Hauptthemen laut MEDLINE: Levonorgestrel, Intrauterine Devices, Medicated, Contraceptive Agents, Female, Metabolome. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Jane and Aatos Erkko Foundation, Finnish Cultural Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Context

Use of a levonorgestrel-releasing intrauterine device (LNG-IUD) has become common irrespective of age and parity. To date, only a few studies have examined its possible metabolic changes and large-scale biomarker profiles in detail and in a longitudinal design.

Objective

To apply the metabolomics technique to examine the metabolic profile associated with the use of LNG-IUD both in a cross-sectional and a longitudinal design.

Design

The study consists of cross-sectional and longitudinal analyses of a population-based survey (Health 2000) and its 11-year follow-up (Health 2011). All participants aged 18 to 49 years with available information on hormonal contraceptive use and metabolomics data (n = 1767) were included. Altogether 212 metabolic measures in LNG-IUD users (n = 341) were compared to those in non-users of hormonal contraception (n = 1426) via multivariable linear regression models. Participants with complete longitudinal information (n = 240) were divided into continuers, stoppers, starters, and never-user groups, and 11-year changes in levels of each metabolite were compared.

Results

After adjustment for covariates, levels of 102 metabolites differed in LNG-IUD current users compared to non-users of hormonal contraception (median difference in biomarker concentration: –0.12 SD): lower levels of fatty acids concentrations and ratios, cholesterol, triglycerides and other lipids, as well as particle concentration, cholesterol, total lipids, and phospholipids in lipoproteins. The 11-year metabolic changes did not differ in relation to changes in LNG-IUD use.

Conclusion

The use of LNG-IUD was associated with several moderate metabolic changes, mostly suggestive of a reduced arterial cardiometabolic risk. Changes in LNG-IUD use were not related to long-term metabolic changes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LevonorgestrelIntrauterine Devices, MedicatedContraceptive Agents, FemaleMetabolomeHumansFemaleAdultMetabolomicsMiddle AgedCross-Sectional StudiesYoung AdultLongitudinal StudiesAdolescentBiomarkersFollow-Up Studies

Stichwörter der Autor:innen

cardiometabolic riskfertile-agedlevonorgestrel-releasing intrauterine devicelongitudinalmetabolic changesmetabolites

Substanzen

LevonorgestrelContraceptive Agents, FemaleBiomarkers

Autor:innen und Institutionen

  • Department of Public Health, Clinicum, Faculty of Medicine, University of Helsinki, 00014 Helsinki, Finland.
  • Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, 00014 Helsinki, Finland.
  • Department of Public Health and Welfare, Finnish Institute for Health and Welfare, FI-00271 Helsinki, Finland.
  • Department of Knowledge Brokers, Finnish Institute for Health and Welfare, FI-00271 Helsinki, Finland.
  • Department of Government Services, Finnish Institute for Health and Welfare, FI-00271 Helsinki, Finland.

ORCID-Profile: Elena Toffol, Oskari Heikinheimo, Lara Lehtoranta, Anni Joensuu, Timo Partonen, Iris Erlund, Jari Haukka

Förderung

  • Jane and Aatos Erkko Foundation
  • Finnish Cultural Foundation

Zitieren

APA

Toffol, E., Heikinheimo, O., Jousilahti, P., Lehtoranta, L., Joensuu, A., Partonen, T., Erlund, I., & Haukka, J. (2025). Moderate Associations Between the Use of Levonorgestrel-releasing Intrauterine Device and Metabolomics Profile. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgae318

Vancouver

Toffol E, Heikinheimo O, Jousilahti P, Lehtoranta L, Joensuu A, Partonen T, et al. Moderate Associations Between the Use of Levonorgestrel-releasing Intrauterine Device and Metabolomics Profile. The Journal of Clinical Endocrinology & Metabolism. 2025. doi:10.1210/clinem/dgae318

BibTeX
@article{Toffol2025,
  author = {Toffol, Elena and Heikinheimo, Oskari and Jousilahti, Pekka and Lehtoranta, Lara and Joensuu, Anni and Partonen, Timo and Erlund, Iris and Haukka, Jari},
  title = {Moderate Associations Between the Use of Levonorgestrel-releasing Intrauterine Device and Metabolomics Profile},
  journal = {The Journal of Clinical Endocrinology & Metabolism},
  year = {2025},
  doi = {10.1210/clinem/dgae318}
}
Kostenlos starten →